J&J and medical device innovation: the pharmaphorum podcastIn episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at Share XJ&J and medical device innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/johnson-medical-device-innovation/
The top 5 pharma M&A deals of 20202020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout Share XThe top 5 pharma M&A deals of 2020https://pharmaphorum.com/views-and-analysis/the-top-5-pharma-ma-deals-of-2020/
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submissionJanssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the Share XJanssen combines Darzalex with COVID-19 drug in new multiple myeloma submissionhttps://pharmaphorum.com/news/janssen-combines-darzalex-with-covid-drug-in-new-multiple-myeloma-submission/
Canada signs deals for J&J, Novavax COVID vaccinesThe Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates. Share XCanada signs deals for J&J, Novavax COVID vaccineshttps://pharmaphorum.com/news/canada-signs-deals-for-jj-novavax-covid-vaccines/
Rebooting the healthcare system post-COVID-19Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake Share XRebooting the healthcare system post-COVID-19https://pharmaphorum.com/views-analysis-digital/rebooting-the-healthcare-system-post-covid-19/
Investing in innovation – new digital approaches for a new decade For the first time in history, we have the technologies that will allow us to develop new Share XInvesting in innovation – new digital approaches for a new decadehttps://pharmaphorum.com/views-analysis-digital/investing-in-innovation-new-digital-approaches-for-a-new-decade/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
J&J strengthens R&D into COVID-19 vaccine with US governmentJohnson & Johnson has announced it has expanded a collaboration with a US government agency to hasten development Share XJ&J strengthens R&D into COVID-19 vaccine with US governmenthttps://pharmaphorum.com/news/jj-strengthens-rd-into-covid-19-vaccine-with-us-government/
3 key trends shaping the immunology marketFrom an increase in sales of interleukin inhibitors to the prevalence of biosimilars, this decade has been an Share X3 key trends shaping the immunology markethttps://pharmaphorum.com/views-analysis-market-access/3-key-trends-shaping-the-immunology-market/
